Breakthrough for itchy dogs
Australian vets are being urged to find out more about an all new approach to providing relief for their canine patients with acute
and chronic itch. Zoetis, a global animal health company, is launching a nationwide campaign to inform vets about a novel treatment strategy for canine pruritus. As part of the campaign, from 7 April to 30 June 2015, Zoetis plans to run several ‘Lunch and Learn’ in-clinic sessions to educate interested veterinary staff about the latest research behind allergic skin disease in canines, and provide information about the launch of Apoquel (oclacitinib) in Australia. The new treatment strategy, which targets the Janus kinase (or JAK) pathway,1,2 rapidly stops the continuous itch cycle without the side effects seen with current therapies. Apoquel has already received an enthusiastic response from dog owners and vets in overseas markets including the USA and New Zealand.
Vets interested in finding out more and requesting a ‘Lunch and Learn’ in-clinic session can either visit the website:
www.apoquel.gettimely.com, or contact Zoetis sales representative Sharon Hill on 1800 880 941.
1. Tizard IR. “Veterinary immunology, an introduction.” 8th ed. St. Louis, MO. Saunders Elsevier, 2009. 2. Abbas AK, Lichtman AH, Pillai S. “Cellular and molecular immunology.” 6th ed. Philadelphia, PA. Saunders Elsevier, 2010.